Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial

Lorenzo Falchi, Fritz Offner, Sven de Vos, Joshua D. Brody, Daniel Morillo, Kim Linton, Sylvia Snauwaert, Michael Roost Clausen, Yasmin H. Karimi, Catherine Thieblemont, Umberto Vitolo, Lori A. Leslie, Mayur S. Narkhede, Raúl Córdoba, Toshihiko Oki, Monica Wielgos-Bonvallet, Mina Khoshdeli, Yi Hao, Kimberly Archer, Malene Risum, David Belada

Open source

DOI: 10.1182/blood.2026033839
Published: 2026-08-11
Container: Blood Journal
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2026033839,
  title = {Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial},
  author = {Lorenzo Falchi and Fritz Offner and Sven de Vos and Joshua D. Brody and Daniel Morillo and Kim Linton and Sylvia Snauwaert and Michael Roost Clausen and Yasmin H. Karimi and Catherine Thieblemont and Umberto Vitolo and Lori A. Leslie and Mayur S. Narkhede and Raúl Córdoba and Toshihiko Oki and Monica Wielgos-Bonvallet and Mina Khoshdeli and Yi Hao and Kimberly Archer and Malene Risum and David Belada},
  year = {2026},
  journal = {Blood Journal},
  doi = {10.1182/blood.2026033839},
  url = {https://doi.org/10.1182/blood.2026033839}
}

RIS

TY  - JOUR
TI  - Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial
AU  - Lorenzo Falchi
AU  - Fritz Offner
AU  - Sven de Vos
AU  - Joshua D. Brody
AU  - Daniel Morillo
AU  - Kim Linton
AU  - Sylvia Snauwaert
AU  - Michael Roost Clausen
AU  - Yasmin H. Karimi
AU  - Catherine Thieblemont
AU  - Umberto Vitolo
AU  - Lori A. Leslie
AU  - Mayur S. Narkhede
AU  - Raúl Córdoba
AU  - Toshihiko Oki
AU  - Monica Wielgos-Bonvallet
AU  - Mina Khoshdeli
AU  - Yi Hao
AU  - Kimberly Archer
AU  - Malene Risum
AU  - David Belada
PY  - 2026
JO  - Blood Journal
DO  - 10.1182/blood.2026033839
UR  - https://doi.org/10.1182/blood.2026033839
ER  -

APA

Falchi, L., Offner, F., Vos, S. D., Brody, J. D., Morillo, D., Linton, K., Snauwaert, S., Clausen, M. R., Karimi, Y. H., Thieblemont, C., Vitolo, U., Leslie, L. A., Narkhede, M. S., Córdoba, R., Oki, T., Wielgos-Bonvallet, M., Khoshdeli, M., Hao, Y., Archer, K., Risum, M., & Belada, D. (2026). Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial. Blood Journal. https://doi.org/10.1182/blood.2026033839

Source records

crossref · retrieved 2026-09-26T09:20:44.125Z